A cohort study revealed high mortality among people who inject drugs in Hai Phong, Vietnam.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
11 2021
Historique:
received: 04 01 2021
revised: 28 06 2021
accepted: 12 07 2021
pubmed: 20 7 2021
medline: 21 12 2021
entrez: 19 7 2021
Statut: ppublish

Résumé

To estimate the residual mortality rate among people who inject drugs (PWID) in a Low-Middle Income Countries context where the HIV epidemic has been controlled and methadone coverage is high. PWID from Haiphong, Vietnam, were recruited through three annual respondent-driven sampling surveys that fueled two cohorts of PWID with HIV (n = 761) and without HIV (n = 897), with bi-annual follow-up. Presumed causes of death were ascertained from medical records and/or interviews of participants family. Among the 1658 participants with a median follow-up of 2 years, 67 and 36 died in the HIV-positive and HIV-negative cohort, respectively, yielding crude mortality rates of 4.3 (95% Confidence interval (CI): 3.3-5.4) per 100 person-years of follow-up (PYFU) and 1.9 (CI: 1.4-2.6) per 100 PYFU. In the HIV-positive cohort, in which 81% of participants had undetectable viral load, the two main causes of death were tuberculosis and HIV-related diseases. In the HIV-negative cohort, the two main causes of death were liver-related diseases and overdose. In a time-dependent multivariable model, "unsuppressed viral load" was associated with increased risk of mortality, whereas "being on methadone" or "being employed" was associated with a lower risk. Despite a very successful HIV and methadone program, the mortality remains high among PWID in Vietnam, largely due to curable infectious diseases such as tuberculosis and viral hepatitis.

Identifiants

pubmed: 34280476
pii: S0895-4356(21)00215-8
doi: 10.1016/j.jclinepi.2021.07.007
pmc: PMC10116693
mid: NIHMS1885001
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-48

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA041978
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

AIDS. 2020 Dec 1;34(15):2305-2311
pubmed: 33048884
Drug Alcohol Depend. 2018 Apr 01;185:106-111
pubmed: 29432973
Drug Alcohol Depend. 2012 Dec 1;126(3):384-8
pubmed: 22728044
AIDS Care. 2016 Oct;28(10):1312-5
pubmed: 27178119
AIDS Behav. 2018 Jul;22(7):2161-2171
pubmed: 28612212
Lancet Infect Dis. 2017 May;17(5):e128-e143
pubmed: 28291721
Clin Infect Dis. 2015 Oct 1;61(7):1157-65
pubmed: 26113656
J Subst Abuse Treat. 2017 Jun;77:166-173
pubmed: 28237351
Addiction. 2011 Mar;106(3):583-9
pubmed: 21054619
Addiction. 2011 Dec;106(12):2186-92
pubmed: 21749525
PLoS Med. 2019 Nov 26;16(11):e1002964
pubmed: 31770391
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Int J Drug Policy. 2016 Jun;32:50-6
pubmed: 27006257
AIDS Behav. 2017 Apr;21(4):1044-1053
pubmed: 28063072
AIDS. 2014 Nov;28 Suppl 4:S435-44
pubmed: 25409098
Addiction. 2015 Jan;110(1):111-9
pubmed: 25203392
Bull World Health Organ. 2013 Feb 1;91(2):102-23
pubmed: 23554523
Clin Infect Dis. 2007 Aug 1;45(3):370-6
pubmed: 17599317
Am J Epidemiol. 2016 Mar 15;183(6):544-52
pubmed: 26865265
Drug Alcohol Depend. 2015 Feb 1;147:215-21
pubmed: 25497590
JAMA Psychiatry. 2020 May 1;77(5):493-502
pubmed: 31876906
Int J Drug Policy. 2016 Apr;30:116-23
pubmed: 26964902
Sci Rep. 2020 Apr 24;10(1):6999
pubmed: 32332986
J Infect Dis. 2017 Dec 27;217(1):64-68
pubmed: 29240903
Adv Prev Med. 2012;2012:732484
pubmed: 23227351
J Int AIDS Soc. 2015 Feb 16;18:19317
pubmed: 25690530
Int J Drug Policy. 2007 Aug;18(4):306-12
pubmed: 17689379
J Food Drug Anal. 2013 Dec;21(4):S42-S45
pubmed: 25278736
Int J Infect Dis. 2016 May;46:56-60
pubmed: 27044521
Lancet Glob Health. 2017 Dec;5(12):e1208-e1220
pubmed: 29074410
Mol Psychiatry. 2019 Dec;24(12):1868-1883
pubmed: 29934549
Drug Alcohol Depend. 2008 Aug 1;96(3):281-5
pubmed: 18434044
Drug Alcohol Depend. 2018 Jul 1;188:274-280
pubmed: 29803034
Lancet. 2018 Sep 1;392(10149):747-759
pubmed: 30191830
Clin Infect Dis. 2016 Oct 15;63(8):1094-1104
pubmed: 27343545

Auteurs

Vu Hai Vinh (VH)

Department of Infectious and Tropical Diseases, Viet Tiep Hospital, Hai Phong, Vietnam.

Roselyne Vallo (R)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France.

Hoang Thi Giang (HT)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Duong Thi Huong (DT)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Khuat Thi Hai Oanh (KTH)

Supporting Community Development Initiatives, Hanoi, Vietnam.

Pham Minh Khue (PM)

Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.

Nham Thi Tuyet Thanh (NTT)

Supporting Community Development Initiatives, Hanoi, Vietnam.

Catherine Quillet (C)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France.

Delphine Rapoud (D)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France.

Laurent Michel (L)

Pierre Nicole Centre, French Red Cross, CESP/Inserm 1018, Paris, France.

Philippe Van de Perre (PV)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France.

Jonathan Feelemyer (J)

New-York University, New York.

Jean Pierre Moles (JP)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France. Electronic address: jean-pierre.moles@inserm.fr.

Amandine Cournil (A)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France.

Don Des Jarlais (DD)

New-York University, New York.

Didier Laureillard (D)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France; Department of Infectious Diseases, Caremeau University Hospital, Nîmes, France.

Nicolas Nagot (N)

Pathogenesis and control of chronic infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France. Electronic address: n-nagot@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH